Lhommel R - Search Results

1

Classification of non-demented patients attending a memory clinic using the new diagnostic criteria for Alzheimer's disease with disease-related biomarkers.

Ivanoiu A, Dricot L, Gilis N, Grandin C, Lhommel R, Quenon L, Hanseeuw B. Ivanoiu A, et al. Among authors: lhommel r. J Alzheimers Dis. 2015;43(3):835-47. doi: 10.3233/JAD-140651. J Alzheimers Dis. 2015. PMID: 25114071

2

Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.

Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N. Jouret F, et al. Among authors: lhommel r. Nephrol Dial Transplant. 2012 Oct;27(10):3746-51. doi: 10.1093/ndt/gfs352. Nephrol Dial Transplant. 2012. PMID: 23114901 Free article. Review.

3

MRI for response assessment in metastatic bone disease.

Lecouvet FE, Larbi A, Pasoglou V, Omoumi P, Tombal B, Michoux N, Malghem J, Lhommel R, Vande Berg BC. Lecouvet FE, et al. Among authors: lhommel r. Eur Radiol. 2013 Jul;23(7):1986-97. doi: 10.1007/s00330-013-2792-3. Epub 2013 Mar 1. Eur Radiol. 2013. PMID: 23455764 Review.

4

Extensive left temporal pole damage does not impact on theory of mind abilities.

Michel C, Dricot L, Lhommel R, Grandin C, Ivanoiu A, Pillon A, Samson D. Michel C, et al. Among authors: lhommel r. J Cogn Neurosci. 2013 Dec;25(12):2025-46. doi: 10.1162/jocn_a_00488. Epub 2013 Sep 18. J Cogn Neurosci. 2013. PMID: 24047381

5

Is 18F-flutemetamol PET/CT able to reveal cardiac amyloidosis?

Lhommel R, Sempoux C, Ivanoiu A, Michaux L, Gerber B. Lhommel R, et al. Clin Nucl Med. 2014 Aug;39(8):747-9. doi: 10.1097/RLU.0000000000000492. Clin Nucl Med. 2014. PMID: 24978329

6

Unirhinal Olfactory Testing for the Diagnostic Workup of Mild Cognitive Impairment.

Huart C, Rombaux P, Gérard T, Hanseeuw B, Lhommel R, Quenon L, Ivanoiu A, Mouraux A. Huart C, et al. Among authors: lhommel r. J Alzheimers Dis. 2015;47(1):253-70. doi: 10.3233/JAD-141494. J Alzheimers Dis. 2015. PMID: 26402773

7

Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.

Pierrot N, Lhommel R, Quenon L, Hanseeuw B, Dricot L, Sindic C, Maloteaux JM, Octavea JN, Ivanoiu A. Pierrot N, et al. Among authors: lhommel r. J Alzheimers Dis. 2016;49(2):271-6. doi: 10.3233/JAD-150405. J Alzheimers Dis. 2016. PMID: 26444777

8

Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.

Hanseeuw B, Dricot L, Lhommel R, Quenon L, Ivanoiu A. Hanseeuw B, et al. Among authors: lhommel r. J Alzheimers Dis. 2016 May 23;53(2):651-60. doi: 10.3233/JAD-160204. J Alzheimers Dis. 2016. PMID: 27232217

9

Prediction of Free and Cued Selective Reminding Test Performance Using Volumetric and Amyloid-Based Biomarkers of Alzheimer's Disease.

Quenon L, Dricot L, Woodard JL, Hanseeuw B, Gilis N, Lhommel R, Ivanoiu A. Quenon L, et al. Among authors: lhommel r. J Int Neuropsychol Soc. 2016 Nov;22(10):991-1004. doi: 10.1017/S1355617716000813. J Int Neuropsychol Soc. 2016. PMID: 27903329

10

Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [¹⁸F] flutemetamol amyloid PET study.

Hanseeuw BJ, Malotaux V, Dricot L, Quenon L, Sznajer Y, Cerman J, Woodard JL, Buckley C, Farrar G, Ivanoiu A, Lhommel R. Hanseeuw BJ, et al. Among authors: lhommel r. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):302-310. doi: 10.1007/s00259-020-04942-4. Epub 2020 Jun 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 32601802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters